nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—Cytochrome P450 2C19 Inhibitors—Topiramate—epilepsy syndrome	0.42	1	CiPCiCtD
Omeprazole—CYP11A1—epilepsy syndrome	0.082	0.425	CbGaD
Omeprazole—ABCG2—epilepsy syndrome	0.0398	0.206	CbGaD
Omeprazole—CYP2C19—epilepsy syndrome	0.0313	0.162	CbGaD
Omeprazole—CYP2D6—epilepsy syndrome	0.0232	0.12	CbGaD
Omeprazole—CYP2C18—Clobazam—epilepsy syndrome	0.0166	0.0643	CbGbCtD
Omeprazole—ABCB1—epilepsy syndrome	0.0166	0.0859	CbGaD
Omeprazole—CYP2C18—Phenytoin—epilepsy syndrome	0.0124	0.0478	CbGbCtD
Omeprazole—ABCC3—Phenobarbital—epilepsy syndrome	0.0121	0.0467	CbGbCtD
Omeprazole—CYP2C18—Propofol—epilepsy syndrome	0.0115	0.0446	CbGbCtD
Omeprazole—CYP2C18—Phenobarbital—epilepsy syndrome	0.011	0.0426	CbGbCtD
Omeprazole—CYP1B1—Propofol—epilepsy syndrome	0.0109	0.0422	CbGbCtD
Omeprazole—CYP2C18—Diazepam—epilepsy syndrome	0.0104	0.0404	CbGbCtD
Omeprazole—CYP1B1—Phenobarbital—epilepsy syndrome	0.0104	0.0403	CbGbCtD
Omeprazole—CYP2C18—Valproic Acid—epilepsy syndrome	0.00824	0.0318	CbGbCtD
Omeprazole—CYP2C8—Trimethadione—epilepsy syndrome	0.00489	0.0189	CbGbCtD
Omeprazole—CYP1A1—Propofol—epilepsy syndrome	0.00479	0.0185	CbGbCtD
Omeprazole—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0046	0.0178	CbGbCtD
Omeprazole—CYP1A1—Phenobarbital—epilepsy syndrome	0.00458	0.0177	CbGbCtD
Omeprazole—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00441	0.0171	CbGbCtD
Omeprazole—CYP2C19—Felbamate—epilepsy syndrome	0.0041	0.0159	CbGbCtD
Omeprazole—CYP2C19—Trimethadione—epilepsy syndrome	0.0041	0.0159	CbGbCtD
Omeprazole—ABCB1—Levetiracetam—epilepsy syndrome	0.00389	0.0151	CbGbCtD
Omeprazole—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00386	0.0149	CbGbCtD
Omeprazole—CYP2C9—Trimethadione—epilepsy syndrome	0.00341	0.0132	CbGbCtD
Omeprazole—CYP2C19—Clobazam—epilepsy syndrome	0.00334	0.0129	CbGbCtD
Omeprazole—CYP2C8—Carbamazepine—epilepsy syndrome	0.0033	0.0128	CbGbCtD
Omeprazole—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00321	0.0124	CbGbCtD
Omeprazole—CYP2C8—Primidone—epilepsy syndrome	0.00308	0.0119	CbGbCtD
Omeprazole—CYP2C8—Phenytoin—epilepsy syndrome	0.00296	0.0115	CbGbCtD
Omeprazole—CYP2C19—Carbamazepine—epilepsy syndrome	0.00277	0.0107	CbGbCtD
Omeprazole—CYP2C8—Propofol—epilepsy syndrome	0.00276	0.0107	CbGbCtD
Omeprazole—ABCB1—Clobazam—epilepsy syndrome	0.0027	0.0104	CbGbCtD
Omeprazole—CYP2C8—Phenobarbital—epilepsy syndrome	0.00264	0.0102	CbGbCtD
Omeprazole—ABCB1—Lamotrigine—epilepsy syndrome	0.0026	0.01	CbGbCtD
Omeprazole—CYP2C19—Primidone—epilepsy syndrome	0.00259	0.01	CbGbCtD
Omeprazole—CYP1A2—Carbamazepine—epilepsy syndrome	0.00256	0.00989	CbGbCtD
Omeprazole—CYP2C8—Diazepam—epilepsy syndrome	0.0025	0.00968	CbGbCtD
Omeprazole—CYP2C19—Phenytoin—epilepsy syndrome	0.00249	0.00961	CbGbCtD
Omeprazole—CYP1A2—Primidone—epilepsy syndrome	0.00239	0.00923	CbGbCtD
Omeprazole—CYP2C19—Propofol—epilepsy syndrome	0.00232	0.00896	CbGbCtD
Omeprazole—CYP2C9—Carbamazepine—epilepsy syndrome	0.0023	0.00891	CbGbCtD
Omeprazole—ABCB1—Carbamazepine—epilepsy syndrome	0.00224	0.00865	CbGbCtD
Omeprazole—CYP2C19—Phenobarbital—epilepsy syndrome	0.00222	0.00857	CbGbCtD
Omeprazole—CYP2C9—Primidone—epilepsy syndrome	0.00215	0.00832	CbGbCtD
Omeprazole—CYP1A2—Propofol—epilepsy syndrome	0.00214	0.00827	CbGbCtD
Omeprazole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00213	0.00825	CbGbCtD
Omeprazole—CYP2C19—Diazepam—epilepsy syndrome	0.0021	0.00812	CbGbCtD
Omeprazole—CYP2C9—Phenytoin—epilepsy syndrome	0.00207	0.00799	CbGbCtD
Omeprazole—CYP2C19—Zonisamide—epilepsy syndrome	0.00205	0.00793	CbGbCtD
Omeprazole—CYP1A2—Phenobarbital—epilepsy syndrome	0.00204	0.00791	CbGbCtD
Omeprazole—ABCB1—Phenytoin—epilepsy syndrome	0.00201	0.00776	CbGbCtD
Omeprazole—CYP3A4—Trimethadione—epilepsy syndrome	0.00198	0.00767	CbGbCtD
Omeprazole—CYP3A4—Felbamate—epilepsy syndrome	0.00198	0.00767	CbGbCtD
Omeprazole—CYP2C8—Valproic Acid—epilepsy syndrome	0.00197	0.00763	CbGbCtD
Omeprazole—CYP1A2—Diazepam—epilepsy syndrome	0.00194	0.00749	CbGbCtD
Omeprazole—CYP2C9—Propofol—epilepsy syndrome	0.00193	0.00745	CbGbCtD
Omeprazole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00186	0.00721	CbGbCtD
Omeprazole—CYP2C9—Phenobarbital—epilepsy syndrome	0.00184	0.00712	CbGbCtD
Omeprazole—ABCB1—Phenobarbital—epilepsy syndrome	0.00179	0.00691	CbGbCtD
Omeprazole—ABCB1—Midazolam—epilepsy syndrome	0.00176	0.00682	CbGbCtD
Omeprazole—CYP2D6—Propofol—epilepsy syndrome	0.00176	0.00682	CbGbCtD
Omeprazole—CYP2C9—Diazepam—epilepsy syndrome	0.00175	0.00675	CbGbCtD
Omeprazole—ABCB1—Diazepam—epilepsy syndrome	0.00169	0.00655	CbGbCtD
Omeprazole—CYP3A4—Clonazepam—epilepsy syndrome	0.00169	0.00652	CbGbCtD
Omeprazole—CYP2C19—Valproic Acid—epilepsy syndrome	0.00166	0.0064	CbGbCtD
Omeprazole—CYP3A4—Clobazam—epilepsy syndrome	0.00162	0.00625	CbGbCtD
Omeprazole—CYP1A2—Valproic Acid—epilepsy syndrome	0.00153	0.00591	CbGbCtD
Omeprazole—CYP2C19—Topiramate—epilepsy syndrome	0.00149	0.00578	CbGbCtD
Omeprazole—CYP2C9—Valproic Acid—epilepsy syndrome	0.00138	0.00532	CbGbCtD
Omeprazole—CYP3A4—Rufinamide—epilepsy syndrome	0.00137	0.00532	CbGbCtD
Omeprazole—CYP3A4—Carbamazepine—epilepsy syndrome	0.00134	0.00518	CbGbCtD
Omeprazole—CYP3A4—Primidone—epilepsy syndrome	0.00125	0.00484	CbGbCtD
Omeprazole—CYP3A4—Phenytoin—epilepsy syndrome	0.0012	0.00465	CbGbCtD
Omeprazole—CYP3A4—Propofol—epilepsy syndrome	0.00112	0.00433	CbGbCtD
Omeprazole—CYP3A4—Acetazolamide—epilepsy syndrome	0.00107	0.00414	CbGbCtD
Omeprazole—CYP3A4—Phenobarbital—epilepsy syndrome	0.00107	0.00414	CbGbCtD
Omeprazole—CYP3A4—Midazolam—epilepsy syndrome	0.00106	0.00408	CbGbCtD
Omeprazole—CYP3A4—Diazepam—epilepsy syndrome	0.00102	0.00393	CbGbCtD
Omeprazole—CYP3A4—Zonisamide—epilepsy syndrome	0.000991	0.00383	CbGbCtD
Omeprazole—CYP3A4—Valproic Acid—epilepsy syndrome	0.0008	0.0031	CbGbCtD
Omeprazole—CYP3A4—Topiramate—epilepsy syndrome	0.000722	0.00279	CbGbCtD
Omeprazole—Esomeprazole—CYP2C19—epilepsy syndrome	0.000199	0.141	CrCbGaD
Omeprazole—Pantoprazole—ABCG2—epilepsy syndrome	0.000183	0.129	CrCbGaD
Omeprazole—Rabeprazole—ABCG2—epilepsy syndrome	0.000183	0.129	CrCbGaD
Omeprazole—Rabeprazole—CYP2C19—epilepsy syndrome	0.000144	0.102	CrCbGaD
Omeprazole—Pantoprazole—CYP2C19—epilepsy syndrome	0.000144	0.102	CrCbGaD
Omeprazole—Lansoprazole—ABCG2—epilepsy syndrome	0.000136	0.0964	CrCbGaD
Omeprazole—Lansoprazole—CYP2C19—epilepsy syndrome	0.000107	0.0758	CrCbGaD
Omeprazole—Rabeprazole—CYP2D6—epilepsy syndrome	0.000106	0.0754	CrCbGaD
Omeprazole—Lansoprazole—CYP2D6—epilepsy syndrome	7.94e-05	0.0562	CrCbGaD
Omeprazole—ATP4A—head—epilepsy syndrome	7.72e-05	0.0505	CbGeAlD
Omeprazole—Pantoprazole—ABCB1—epilepsy syndrome	7.6e-05	0.0538	CrCbGaD
Omeprazole—ATP4A—nervous system—epilepsy syndrome	7.32e-05	0.0479	CbGeAlD
Omeprazole—ATP4A—central nervous system—epilepsy syndrome	7.04e-05	0.0461	CbGeAlD
Omeprazole—ATP4A—cerebellum—epilepsy syndrome	6.89e-05	0.0451	CbGeAlD
Omeprazole—CYP11A1—medulla oblongata—epilepsy syndrome	6.38e-05	0.0418	CbGeAlD
Omeprazole—Lansoprazole—ABCB1—epilepsy syndrome	5.67e-05	0.0401	CrCbGaD
Omeprazole—ATP4A—brain—epilepsy syndrome	5.59e-05	0.0366	CbGeAlD
Omeprazole—CYP11A1—head—epilepsy syndrome	5.06e-05	0.0331	CbGeAlD
Omeprazole—CYP2D6—hindbrain—epilepsy syndrome	4.95e-05	0.0324	CbGeAlD
Omeprazole—CYP1B1—telencephalon—epilepsy syndrome	4.93e-05	0.0323	CbGeAlD
Omeprazole—CYP11A1—nervous system—epilepsy syndrome	4.8e-05	0.0314	CbGeAlD
Omeprazole—CYP11A1—central nervous system—epilepsy syndrome	4.62e-05	0.0302	CbGeAlD
Omeprazole—ABCC3—head—epilepsy syndrome	3.93e-05	0.0257	CbGeAlD
Omeprazole—ABCC3—nervous system—epilepsy syndrome	3.72e-05	0.0244	CbGeAlD
Omeprazole—ABCG2—telencephalon—epilepsy syndrome	3.67e-05	0.0241	CbGeAlD
Omeprazole—CYP11A1—brain—epilepsy syndrome	3.67e-05	0.024	CbGeAlD
Omeprazole—ABCC3—central nervous system—epilepsy syndrome	3.58e-05	0.0235	CbGeAlD
Omeprazole—CYP1B1—head—epilepsy syndrome	3.07e-05	0.0201	CbGeAlD
Omeprazole—CYP1B1—nervous system—epilepsy syndrome	2.91e-05	0.0191	CbGeAlD
Omeprazole—ABCG2—medulla oblongata—epilepsy syndrome	2.89e-05	0.0189	CbGeAlD
Omeprazole—ABCC3—brain—epilepsy syndrome	2.85e-05	0.0186	CbGeAlD
Omeprazole—CYP2D6—brainstem—epilepsy syndrome	2.84e-05	0.0186	CbGeAlD
Omeprazole—CYP1B1—central nervous system—epilepsy syndrome	2.8e-05	0.0184	CbGeAlD
Omeprazole—CYP1B1—cerebellum—epilepsy syndrome	2.74e-05	0.018	CbGeAlD
Omeprazole—CYP2D6—forebrain—epilepsy syndrome	2.74e-05	0.0179	CbGeAlD
Omeprazole—ABCG2—midbrain—epilepsy syndrome	2.64e-05	0.0173	CbGeAlD
Omeprazole—ABCG2—spinal cord—epilepsy syndrome	2.57e-05	0.0169	CbGeAlD
Omeprazole—CYP2D6—telencephalon—epilepsy syndrome	2.52e-05	0.0165	CbGeAlD
Omeprazole—CYP1B1—brain—epilepsy syndrome	2.23e-05	0.0146	CbGeAlD
Omeprazole—CYP1A1—head—epilepsy syndrome	2.17e-05	0.0142	CbGeAlD
Omeprazole—CYP1A1—nervous system—epilepsy syndrome	2.06e-05	0.0135	CbGeAlD
Omeprazole—ABCG2—cerebellum—epilepsy syndrome	2.04e-05	0.0134	CbGeAlD
Omeprazole—CYP1A1—central nervous system—epilepsy syndrome	1.98e-05	0.013	CbGeAlD
Omeprazole—ABCB1—forebrain—epilepsy syndrome	1.97e-05	0.0129	CbGeAlD
Omeprazole—ABCB1—telencephalon—epilepsy syndrome	1.81e-05	0.0119	CbGeAlD
Omeprazole—CYP2C8—brain—epilepsy syndrome	1.71e-05	0.0112	CbGeAlD
Omeprazole—ABCG2—brain—epilepsy syndrome	1.66e-05	0.0109	CbGeAlD
Omeprazole—CYP1A1—brain—epilepsy syndrome	1.57e-05	0.0103	CbGeAlD
Omeprazole—CYP2D6—head—epilepsy syndrome	1.57e-05	0.0103	CbGeAlD
Omeprazole—CYP3A4—nervous system—epilepsy syndrome	1.51e-05	0.0099	CbGeAlD
Omeprazole—CYP2D6—nervous system—epilepsy syndrome	1.49e-05	0.00974	CbGeAlD
Omeprazole—CYP3A4—central nervous system—epilepsy syndrome	1.45e-05	0.00953	CbGeAlD
Omeprazole—CYP2D6—central nervous system—epilepsy syndrome	1.43e-05	0.00937	CbGeAlD
Omeprazole—ABCB1—medulla oblongata—epilepsy syndrome	1.42e-05	0.00932	CbGeAlD
Omeprazole—Anorexia—Valproic Acid—epilepsy syndrome	1.4e-05	0.000155	CcSEcCtD
Omeprazole—Tremor—Gabapentin—epilepsy syndrome	1.4e-05	0.000155	CcSEcCtD
Omeprazole—CYP2D6—cerebellum—epilepsy syndrome	1.4e-05	0.00916	CbGeAlD
Omeprazole—Rash—Diazepam—epilepsy syndrome	1.4e-05	0.000154	CcSEcCtD
Omeprazole—Dermatitis—Diazepam—epilepsy syndrome	1.39e-05	0.000154	CcSEcCtD
Omeprazole—Visual impairment—Topiramate—epilepsy syndrome	1.39e-05	0.000154	CcSEcCtD
Omeprazole—Chest pain—Pregabalin—epilepsy syndrome	1.39e-05	0.000153	CcSEcCtD
Omeprazole—Myalgia—Pregabalin—epilepsy syndrome	1.39e-05	0.000153	CcSEcCtD
Omeprazole—Arthralgia—Pregabalin—epilepsy syndrome	1.39e-05	0.000153	CcSEcCtD
Omeprazole—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.39e-05	0.000153	CcSEcCtD
Omeprazole—Dizziness—Zonisamide—epilepsy syndrome	1.39e-05	0.000153	CcSEcCtD
Omeprazole—Headache—Diazepam—epilepsy syndrome	1.39e-05	0.000153	CcSEcCtD
Omeprazole—Anxiety—Pregabalin—epilepsy syndrome	1.38e-05	0.000153	CcSEcCtD
Omeprazole—Diarrhoea—Clonazepam—epilepsy syndrome	1.38e-05	0.000153	CcSEcCtD
Omeprazole—Anaemia—Gabapentin—epilepsy syndrome	1.38e-05	0.000153	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.38e-05	0.000152	CcSEcCtD
Omeprazole—Asthenia—Carbamazepine—epilepsy syndrome	1.38e-05	0.000152	CcSEcCtD
Omeprazole—Agitation—Gabapentin—epilepsy syndrome	1.37e-05	0.000152	CcSEcCtD
Omeprazole—Diarrhoea—Phenytoin—epilepsy syndrome	1.37e-05	0.000152	CcSEcCtD
Omeprazole—Discomfort—Pregabalin—epilepsy syndrome	1.37e-05	0.000152	CcSEcCtD
Omeprazole—Nausea—Fosphenytoin—epilepsy syndrome	1.37e-05	0.000151	CcSEcCtD
Omeprazole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.37e-05	0.000151	CcSEcCtD
Omeprazole—Erythema multiforme—Topiramate—epilepsy syndrome	1.37e-05	0.000151	CcSEcCtD
Omeprazole—Angioedema—Gabapentin—epilepsy syndrome	1.37e-05	0.000151	CcSEcCtD
Omeprazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.36e-05	0.000151	CcSEcCtD
Omeprazole—Vomiting—Felbamate—epilepsy syndrome	1.36e-05	0.000151	CcSEcCtD
Omeprazole—Dry mouth—Pregabalin—epilepsy syndrome	1.36e-05	0.00015	CcSEcCtD
Omeprazole—Pruritus—Carbamazepine—epilepsy syndrome	1.36e-05	0.00015	CcSEcCtD
Omeprazole—Rash—Felbamate—epilepsy syndrome	1.35e-05	0.000149	CcSEcCtD
Omeprazole—Eye disorder—Topiramate—epilepsy syndrome	1.35e-05	0.000149	CcSEcCtD
Omeprazole—Dermatitis—Felbamate—epilepsy syndrome	1.35e-05	0.000149	CcSEcCtD
Omeprazole—Malaise—Gabapentin—epilepsy syndrome	1.35e-05	0.000149	CcSEcCtD
Omeprazole—Tinnitus—Topiramate—epilepsy syndrome	1.35e-05	0.000149	CcSEcCtD
Omeprazole—Vertigo—Gabapentin—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Omeprazole—Headache—Felbamate—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Omeprazole—Confusional state—Pregabalin—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Omeprazole—Flushing—Topiramate—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Omeprazole—Leukopenia—Gabapentin—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Omeprazole—Dizziness—Clonazepam—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Omeprazole—Nausea—Vigabatrin—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Omeprazole—Vomiting—Zonisamide—epilepsy syndrome	1.33e-05	0.000147	CcSEcCtD
Omeprazole—Insomnia—Valproic Acid—epilepsy syndrome	1.33e-05	0.000147	CcSEcCtD
Omeprazole—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.33e-05	0.000147	CcSEcCtD
Omeprazole—Asthenia—Lamotrigine—epilepsy syndrome	1.33e-05	0.000147	CcSEcCtD
Omeprazole—Dizziness—Phenytoin—epilepsy syndrome	1.33e-05	0.000147	CcSEcCtD
Omeprazole—Rash—Zonisamide—epilepsy syndrome	1.32e-05	0.000146	CcSEcCtD
Omeprazole—Infection—Pregabalin—epilepsy syndrome	1.32e-05	0.000146	CcSEcCtD
Omeprazole—Paraesthesia—Valproic Acid—epilepsy syndrome	1.32e-05	0.000146	CcSEcCtD
Omeprazole—Palpitations—Gabapentin—epilepsy syndrome	1.32e-05	0.000146	CcSEcCtD
Omeprazole—Dermatitis—Zonisamide—epilepsy syndrome	1.32e-05	0.000146	CcSEcCtD
Omeprazole—Dizziness—Oxcarbazepine—epilepsy syndrome	1.32e-05	0.000146	CcSEcCtD
Omeprazole—Nausea—Diazepam—epilepsy syndrome	1.32e-05	0.000145	CcSEcCtD
Omeprazole—Headache—Zonisamide—epilepsy syndrome	1.31e-05	0.000145	CcSEcCtD
Omeprazole—Dyspnoea—Valproic Acid—epilepsy syndrome	1.31e-05	0.000145	CcSEcCtD
Omeprazole—Diarrhoea—Carbamazepine—epilepsy syndrome	1.31e-05	0.000145	CcSEcCtD
Omeprazole—Pruritus—Lamotrigine—epilepsy syndrome	1.31e-05	0.000145	CcSEcCtD
Omeprazole—Shock—Pregabalin—epilepsy syndrome	1.31e-05	0.000145	CcSEcCtD
Omeprazole—Somnolence—Valproic Acid—epilepsy syndrome	1.31e-05	0.000145	CcSEcCtD
Omeprazole—Immune system disorder—Topiramate—epilepsy syndrome	1.31e-05	0.000144	CcSEcCtD
Omeprazole—Nervous system disorder—Pregabalin—epilepsy syndrome	1.31e-05	0.000144	CcSEcCtD
Omeprazole—Cough—Gabapentin—epilepsy syndrome	1.3e-05	0.000144	CcSEcCtD
Omeprazole—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.3e-05	0.000144	CcSEcCtD
Omeprazole—Mediastinal disorder—Topiramate—epilepsy syndrome	1.3e-05	0.000144	CcSEcCtD
Omeprazole—ABCB1—midbrain—epilepsy syndrome	1.3e-05	0.00852	CbGeAlD
Omeprazole—Tachycardia—Pregabalin—epilepsy syndrome	1.3e-05	0.000144	CcSEcCtD
Omeprazole—Chills—Topiramate—epilepsy syndrome	1.3e-05	0.000143	CcSEcCtD
Omeprazole—Dyspepsia—Valproic Acid—epilepsy syndrome	1.3e-05	0.000143	CcSEcCtD
Omeprazole—Skin disorder—Pregabalin—epilepsy syndrome	1.29e-05	0.000143	CcSEcCtD
Omeprazole—Hypertension—Gabapentin—epilepsy syndrome	1.29e-05	0.000143	CcSEcCtD
Omeprazole—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.29e-05	0.000142	CcSEcCtD
Omeprazole—Vomiting—Clonazepam—epilepsy syndrome	1.29e-05	0.000142	CcSEcCtD
Omeprazole—Decreased appetite—Valproic Acid—epilepsy syndrome	1.28e-05	0.000141	CcSEcCtD
Omeprazole—Alopecia—Topiramate—epilepsy syndrome	1.28e-05	0.000141	CcSEcCtD
Omeprazole—Vomiting—Phenytoin—epilepsy syndrome	1.28e-05	0.000141	CcSEcCtD
Omeprazole—Rash—Clonazepam—epilepsy syndrome	1.27e-05	0.000141	CcSEcCtD
Omeprazole—Dermatitis—Clonazepam—epilepsy syndrome	1.27e-05	0.000141	CcSEcCtD
Omeprazole—Arthralgia—Gabapentin—epilepsy syndrome	1.27e-05	0.000141	CcSEcCtD
Omeprazole—Chest pain—Gabapentin—epilepsy syndrome	1.27e-05	0.000141	CcSEcCtD
Omeprazole—Myalgia—Gabapentin—epilepsy syndrome	1.27e-05	0.000141	CcSEcCtD
Omeprazole—Nausea—Felbamate—epilepsy syndrome	1.27e-05	0.000141	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—Vomiting—Oxcarbazepine—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—ABCB1—spinal cord—epilepsy syndrome	1.27e-05	0.00831	CbGeAlD
Omeprazole—Fatigue—Valproic Acid—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—Anxiety—Gabapentin—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—Anorexia—Pregabalin—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—Dizziness—Carbamazepine—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—Diarrhoea—Lamotrigine—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—Headache—Clonazepam—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—Rash—Phenytoin—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—Mental disorder—Topiramate—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Omeprazole—Dermatitis—Phenytoin—epilepsy syndrome	1.26e-05	0.00014	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.26e-05	0.00014	CcSEcCtD
Omeprazole—Rash—Oxcarbazepine—epilepsy syndrome	1.26e-05	0.000139	CcSEcCtD
Omeprazole—Constipation—Valproic Acid—epilepsy syndrome	1.26e-05	0.000139	CcSEcCtD
Omeprazole—Pain—Valproic Acid—epilepsy syndrome	1.26e-05	0.000139	CcSEcCtD
Omeprazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.26e-05	0.000139	CcSEcCtD
Omeprazole—Headache—Phenytoin—epilepsy syndrome	1.26e-05	0.000139	CcSEcCtD
Omeprazole—Malnutrition—Topiramate—epilepsy syndrome	1.26e-05	0.000139	CcSEcCtD
Omeprazole—Discomfort—Gabapentin—epilepsy syndrome	1.26e-05	0.000139	CcSEcCtD
Omeprazole—Headache—Oxcarbazepine—epilepsy syndrome	1.25e-05	0.000138	CcSEcCtD
Omeprazole—Nausea—Zonisamide—epilepsy syndrome	1.25e-05	0.000138	CcSEcCtD
Omeprazole—Dry mouth—Gabapentin—epilepsy syndrome	1.24e-05	0.000138	CcSEcCtD
Omeprazole—Flatulence—Topiramate—epilepsy syndrome	1.24e-05	0.000137	CcSEcCtD
Omeprazole—Tension—Topiramate—epilepsy syndrome	1.23e-05	0.000136	CcSEcCtD
Omeprazole—Dysgeusia—Topiramate—epilepsy syndrome	1.23e-05	0.000136	CcSEcCtD
Omeprazole—Confusional state—Gabapentin—epilepsy syndrome	1.23e-05	0.000136	CcSEcCtD
Omeprazole—Dizziness—Lamotrigine—epilepsy syndrome	1.23e-05	0.000135	CcSEcCtD
Omeprazole—Nervousness—Topiramate—epilepsy syndrome	1.22e-05	0.000135	CcSEcCtD
Omeprazole—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.22e-05	0.000135	CcSEcCtD
Omeprazole—Vomiting—Carbamazepine—epilepsy syndrome	1.22e-05	0.000135	CcSEcCtD
Omeprazole—Back pain—Topiramate—epilepsy syndrome	1.22e-05	0.000134	CcSEcCtD
Omeprazole—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.21e-05	0.000134	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.21e-05	0.000134	CcSEcCtD
Omeprazole—Infection—Gabapentin—epilepsy syndrome	1.21e-05	0.000134	CcSEcCtD
Omeprazole—Muscle spasms—Topiramate—epilepsy syndrome	1.21e-05	0.000134	CcSEcCtD
Omeprazole—Rash—Carbamazepine—epilepsy syndrome	1.21e-05	0.000134	CcSEcCtD
Omeprazole—Dermatitis—Carbamazepine—epilepsy syndrome	1.21e-05	0.000133	CcSEcCtD
Omeprazole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.2e-05	0.000133	CcSEcCtD
Omeprazole—Insomnia—Pregabalin—epilepsy syndrome	1.2e-05	0.000133	CcSEcCtD
Omeprazole—Nausea—Clonazepam—epilepsy syndrome	1.2e-05	0.000133	CcSEcCtD
Omeprazole—Headache—Carbamazepine—epilepsy syndrome	1.2e-05	0.000133	CcSEcCtD
Omeprazole—Shock—Gabapentin—epilepsy syndrome	1.2e-05	0.000133	CcSEcCtD
Omeprazole—Nervous system disorder—Gabapentin—epilepsy syndrome	1.2e-05	0.000132	CcSEcCtD
Omeprazole—Paraesthesia—Pregabalin—epilepsy syndrome	1.19e-05	0.000132	CcSEcCtD
Omeprazole—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.19e-05	0.000132	CcSEcCtD
Omeprazole—Nausea—Phenytoin—epilepsy syndrome	1.19e-05	0.000132	CcSEcCtD
Omeprazole—Tachycardia—Gabapentin—epilepsy syndrome	1.19e-05	0.000132	CcSEcCtD
Omeprazole—Dyspnoea—Pregabalin—epilepsy syndrome	1.19e-05	0.000131	CcSEcCtD
Omeprazole—Nausea—Oxcarbazepine—epilepsy syndrome	1.19e-05	0.000131	CcSEcCtD
Omeprazole—Vision blurred—Topiramate—epilepsy syndrome	1.19e-05	0.000131	CcSEcCtD
Omeprazole—Skin disorder—Gabapentin—epilepsy syndrome	1.19e-05	0.000131	CcSEcCtD
Omeprazole—Somnolence—Pregabalin—epilepsy syndrome	1.18e-05	0.000131	CcSEcCtD
Omeprazole—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.18e-05	0.00013	CcSEcCtD
Omeprazole—Tremor—Topiramate—epilepsy syndrome	1.18e-05	0.00013	CcSEcCtD
Omeprazole—Vomiting—Lamotrigine—epilepsy syndrome	1.18e-05	0.00013	CcSEcCtD
Omeprazole—Urticaria—Valproic Acid—epilepsy syndrome	1.17e-05	0.000129	CcSEcCtD
Omeprazole—Rash—Lamotrigine—epilepsy syndrome	1.17e-05	0.000129	CcSEcCtD
Omeprazole—Ill-defined disorder—Topiramate—epilepsy syndrome	1.17e-05	0.000129	CcSEcCtD
Omeprazole—Dermatitis—Lamotrigine—epilepsy syndrome	1.17e-05	0.000129	CcSEcCtD
Omeprazole—Body temperature increased—Valproic Acid—epilepsy syndrome	1.16e-05	0.000129	CcSEcCtD
Omeprazole—Abdominal pain—Valproic Acid—epilepsy syndrome	1.16e-05	0.000129	CcSEcCtD
Omeprazole—Anorexia—Gabapentin—epilepsy syndrome	1.16e-05	0.000129	CcSEcCtD
Omeprazole—Anaemia—Topiramate—epilepsy syndrome	1.16e-05	0.000129	CcSEcCtD
Omeprazole—Headache—Lamotrigine—epilepsy syndrome	1.16e-05	0.000128	CcSEcCtD
Omeprazole—Decreased appetite—Pregabalin—epilepsy syndrome	1.16e-05	0.000128	CcSEcCtD
Omeprazole—Agitation—Topiramate—epilepsy syndrome	1.16e-05	0.000128	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.15e-05	0.000127	CcSEcCtD
Omeprazole—Fatigue—Pregabalin—epilepsy syndrome	1.15e-05	0.000127	CcSEcCtD
Omeprazole—Nausea—Carbamazepine—epilepsy syndrome	1.14e-05	0.000126	CcSEcCtD
Omeprazole—Constipation—Pregabalin—epilepsy syndrome	1.14e-05	0.000126	CcSEcCtD
Omeprazole—Pain—Pregabalin—epilepsy syndrome	1.14e-05	0.000126	CcSEcCtD
Omeprazole—CYP2D6—brain—epilepsy syndrome	1.14e-05	0.00744	CbGeAlD
Omeprazole—Malaise—Topiramate—epilepsy syndrome	1.13e-05	0.000125	CcSEcCtD
Omeprazole—Vertigo—Topiramate—epilepsy syndrome	1.13e-05	0.000125	CcSEcCtD
Omeprazole—ABCB1—head—epilepsy syndrome	1.13e-05	0.00739	CbGeAlD
Omeprazole—Leukopenia—Topiramate—epilepsy syndrome	1.13e-05	0.000124	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.11e-05	0.000123	CcSEcCtD
Omeprazole—Palpitations—Topiramate—epilepsy syndrome	1.11e-05	0.000123	CcSEcCtD
Omeprazole—Insomnia—Gabapentin—epilepsy syndrome	1.1e-05	0.000122	CcSEcCtD
Omeprazole—Nausea—Lamotrigine—epilepsy syndrome	1.1e-05	0.000122	CcSEcCtD
Omeprazole—Cough—Topiramate—epilepsy syndrome	1.1e-05	0.000121	CcSEcCtD
Omeprazole—Feeling abnormal—Pregabalin—epilepsy syndrome	1.1e-05	0.000121	CcSEcCtD
Omeprazole—Paraesthesia—Gabapentin—epilepsy syndrome	1.1e-05	0.000121	CcSEcCtD
Omeprazole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.09e-05	0.00012	CcSEcCtD
Omeprazole—Dyspnoea—Gabapentin—epilepsy syndrome	1.09e-05	0.00012	CcSEcCtD
Omeprazole—Hypertension—Topiramate—epilepsy syndrome	1.09e-05	0.00012	CcSEcCtD
Omeprazole—Somnolence—Gabapentin—epilepsy syndrome	1.08e-05	0.00012	CcSEcCtD
Omeprazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.08e-05	0.00012	CcSEcCtD
Omeprazole—Dyspepsia—Gabapentin—epilepsy syndrome	1.07e-05	0.000119	CcSEcCtD
Omeprazole—Myalgia—Topiramate—epilepsy syndrome	1.07e-05	0.000118	CcSEcCtD
Omeprazole—Chest pain—Topiramate—epilepsy syndrome	1.07e-05	0.000118	CcSEcCtD
Omeprazole—Arthralgia—Topiramate—epilepsy syndrome	1.07e-05	0.000118	CcSEcCtD
Omeprazole—ABCB1—nervous system—epilepsy syndrome	1.07e-05	0.007	CbGeAlD
Omeprazole—Anxiety—Topiramate—epilepsy syndrome	1.07e-05	0.000118	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.06e-05	0.000118	CcSEcCtD
Omeprazole—Decreased appetite—Gabapentin—epilepsy syndrome	1.06e-05	0.000117	CcSEcCtD
Omeprazole—Discomfort—Topiramate—epilepsy syndrome	1.06e-05	0.000117	CcSEcCtD
Omeprazole—Urticaria—Pregabalin—epilepsy syndrome	1.06e-05	0.000117	CcSEcCtD
Omeprazole—Asthenia—Valproic Acid—epilepsy syndrome	1.06e-05	0.000117	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.05e-05	0.000116	CcSEcCtD
Omeprazole—Fatigue—Gabapentin—epilepsy syndrome	1.05e-05	0.000116	CcSEcCtD
Omeprazole—Body temperature increased—Pregabalin—epilepsy syndrome	1.05e-05	0.000116	CcSEcCtD
Omeprazole—Abdominal pain—Pregabalin—epilepsy syndrome	1.05e-05	0.000116	CcSEcCtD
Omeprazole—Dry mouth—Topiramate—epilepsy syndrome	1.05e-05	0.000116	CcSEcCtD
Omeprazole—Pain—Gabapentin—epilepsy syndrome	1.04e-05	0.000115	CcSEcCtD
Omeprazole—Constipation—Gabapentin—epilepsy syndrome	1.04e-05	0.000115	CcSEcCtD
Omeprazole—Pruritus—Valproic Acid—epilepsy syndrome	1.04e-05	0.000115	CcSEcCtD
Omeprazole—Confusional state—Topiramate—epilepsy syndrome	1.04e-05	0.000114	CcSEcCtD
Omeprazole—ABCB1—central nervous system—epilepsy syndrome	1.03e-05	0.00674	CbGeAlD
Omeprazole—Infection—Topiramate—epilepsy syndrome	1.02e-05	0.000113	CcSEcCtD
Omeprazole—Shock—Topiramate—epilepsy syndrome	1.01e-05	0.000112	CcSEcCtD
Omeprazole—Diarrhoea—Valproic Acid—epilepsy syndrome	1.01e-05	0.000111	CcSEcCtD
Omeprazole—Nervous system disorder—Topiramate—epilepsy syndrome	1.01e-05	0.000111	CcSEcCtD
Omeprazole—ABCB1—cerebellum—epilepsy syndrome	1.01e-05	0.00659	CbGeAlD
Omeprazole—Feeling abnormal—Gabapentin—epilepsy syndrome	1.01e-05	0.000111	CcSEcCtD
Omeprazole—Thrombocytopenia—Topiramate—epilepsy syndrome	1.01e-05	0.000111	CcSEcCtD
Omeprazole—Tachycardia—Topiramate—epilepsy syndrome	1e-05	0.000111	CcSEcCtD
Omeprazole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	9.98e-06	0.00011	CcSEcCtD
Omeprazole—Skin disorder—Topiramate—epilepsy syndrome	9.97e-06	0.00011	CcSEcCtD
Omeprazole—Hyperhidrosis—Topiramate—epilepsy syndrome	9.93e-06	0.00011	CcSEcCtD
Omeprazole—Hypersensitivity—Pregabalin—epilepsy syndrome	9.8e-06	0.000108	CcSEcCtD
Omeprazole—Anorexia—Topiramate—epilepsy syndrome	9.79e-06	0.000108	CcSEcCtD
Omeprazole—Dizziness—Valproic Acid—epilepsy syndrome	9.73e-06	0.000108	CcSEcCtD
Omeprazole—Urticaria—Gabapentin—epilepsy syndrome	9.69e-06	0.000107	CcSEcCtD
Omeprazole—Body temperature increased—Gabapentin—epilepsy syndrome	9.65e-06	0.000107	CcSEcCtD
Omeprazole—Abdominal pain—Gabapentin—epilepsy syndrome	9.65e-06	0.000107	CcSEcCtD
Omeprazole—Asthenia—Pregabalin—epilepsy syndrome	9.55e-06	0.000106	CcSEcCtD
Omeprazole—Pruritus—Pregabalin—epilepsy syndrome	9.42e-06	0.000104	CcSEcCtD
Omeprazole—Vomiting—Valproic Acid—epilepsy syndrome	9.36e-06	0.000103	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.35e-06	0.000103	CcSEcCtD
Omeprazole—Insomnia—Topiramate—epilepsy syndrome	9.29e-06	0.000103	CcSEcCtD
Omeprazole—Rash—Valproic Acid—epilepsy syndrome	9.28e-06	0.000103	CcSEcCtD
Omeprazole—Dermatitis—Valproic Acid—epilepsy syndrome	9.27e-06	0.000102	CcSEcCtD
Omeprazole—Headache—Valproic Acid—epilepsy syndrome	9.22e-06	0.000102	CcSEcCtD
Omeprazole—Paraesthesia—Topiramate—epilepsy syndrome	9.22e-06	0.000102	CcSEcCtD
Omeprazole—Dyspnoea—Topiramate—epilepsy syndrome	9.15e-06	0.000101	CcSEcCtD
Omeprazole—Somnolence—Topiramate—epilepsy syndrome	9.13e-06	0.000101	CcSEcCtD
Omeprazole—Diarrhoea—Pregabalin—epilepsy syndrome	9.11e-06	0.000101	CcSEcCtD
Omeprazole—Dyspepsia—Topiramate—epilepsy syndrome	9.04e-06	9.99e-05	CcSEcCtD
Omeprazole—Hypersensitivity—Gabapentin—epilepsy syndrome	8.99e-06	9.94e-05	CcSEcCtD
Omeprazole—Decreased appetite—Topiramate—epilepsy syndrome	8.92e-06	9.86e-05	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.86e-06	9.8e-05	CcSEcCtD
Omeprazole—Fatigue—Topiramate—epilepsy syndrome	8.85e-06	9.78e-05	CcSEcCtD
Omeprazole—Dizziness—Pregabalin—epilepsy syndrome	8.8e-06	9.73e-05	CcSEcCtD
Omeprazole—Constipation—Topiramate—epilepsy syndrome	8.78e-06	9.7e-05	CcSEcCtD
Omeprazole—Pain—Topiramate—epilepsy syndrome	8.78e-06	9.7e-05	CcSEcCtD
Omeprazole—Asthenia—Gabapentin—epilepsy syndrome	8.76e-06	9.68e-05	CcSEcCtD
Omeprazole—Nausea—Valproic Acid—epilepsy syndrome	8.74e-06	9.66e-05	CcSEcCtD
Omeprazole—Pruritus—Gabapentin—epilepsy syndrome	8.63e-06	9.54e-05	CcSEcCtD
Omeprazole—Vomiting—Pregabalin—epilepsy syndrome	8.46e-06	9.35e-05	CcSEcCtD
Omeprazole—Feeling abnormal—Topiramate—epilepsy syndrome	8.46e-06	9.35e-05	CcSEcCtD
Omeprazole—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.4e-06	9.28e-05	CcSEcCtD
Omeprazole—Rash—Pregabalin—epilepsy syndrome	8.39e-06	9.27e-05	CcSEcCtD
Omeprazole—Dermatitis—Pregabalin—epilepsy syndrome	8.38e-06	9.27e-05	CcSEcCtD
Omeprazole—Diarrhoea—Gabapentin—epilepsy syndrome	8.35e-06	9.23e-05	CcSEcCtD
Omeprazole—Headache—Pregabalin—epilepsy syndrome	8.34e-06	9.21e-05	CcSEcCtD
Omeprazole—ABCB1—brain—epilepsy syndrome	8.18e-06	0.00535	CbGeAlD
Omeprazole—Urticaria—Topiramate—epilepsy syndrome	8.16e-06	9.01e-05	CcSEcCtD
Omeprazole—Abdominal pain—Topiramate—epilepsy syndrome	8.12e-06	8.97e-05	CcSEcCtD
Omeprazole—Body temperature increased—Topiramate—epilepsy syndrome	8.12e-06	8.97e-05	CcSEcCtD
Omeprazole—Dizziness—Gabapentin—epilepsy syndrome	8.07e-06	8.92e-05	CcSEcCtD
Omeprazole—Nausea—Pregabalin—epilepsy syndrome	7.9e-06	8.74e-05	CcSEcCtD
Omeprazole—Vomiting—Gabapentin—epilepsy syndrome	7.76e-06	8.58e-05	CcSEcCtD
Omeprazole—Rash—Gabapentin—epilepsy syndrome	7.69e-06	8.5e-05	CcSEcCtD
Omeprazole—Dermatitis—Gabapentin—epilepsy syndrome	7.69e-06	8.5e-05	CcSEcCtD
Omeprazole—Headache—Gabapentin—epilepsy syndrome	7.64e-06	8.45e-05	CcSEcCtD
Omeprazole—Hypersensitivity—Topiramate—epilepsy syndrome	7.56e-06	8.36e-05	CcSEcCtD
Omeprazole—Asthenia—Topiramate—epilepsy syndrome	7.37e-06	8.14e-05	CcSEcCtD
Omeprazole—Pruritus—Topiramate—epilepsy syndrome	7.26e-06	8.03e-05	CcSEcCtD
Omeprazole—Nausea—Gabapentin—epilepsy syndrome	7.25e-06	8.01e-05	CcSEcCtD
Omeprazole—Diarrhoea—Topiramate—epilepsy syndrome	7.02e-06	7.76e-05	CcSEcCtD
Omeprazole—Dizziness—Topiramate—epilepsy syndrome	6.79e-06	7.5e-05	CcSEcCtD
Omeprazole—Vomiting—Topiramate—epilepsy syndrome	6.53e-06	7.21e-05	CcSEcCtD
Omeprazole—Rash—Topiramate—epilepsy syndrome	6.47e-06	7.15e-05	CcSEcCtD
Omeprazole—Dermatitis—Topiramate—epilepsy syndrome	6.47e-06	7.15e-05	CcSEcCtD
Omeprazole—Headache—Topiramate—epilepsy syndrome	6.43e-06	7.11e-05	CcSEcCtD
Omeprazole—Nausea—Topiramate—epilepsy syndrome	6.1e-06	6.74e-05	CcSEcCtD
Omeprazole—CYP1B1—Metabolism—HMOX1—epilepsy syndrome	2.19e-06	6.31e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	2.19e-06	6.29e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.18e-06	6.26e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	2.17e-06	6.23e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CAT—epilepsy syndrome	2.16e-06	6.23e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	2.14e-06	6.17e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	2.14e-06	6.17e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.13e-06	6.13e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.12e-06	6.1e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ABCB1—epilepsy syndrome	2.11e-06	6.06e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AQP1—epilepsy syndrome	2.1e-06	6.05e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	2.1e-06	6.04e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.09e-06	6.02e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.09e-06	6.02e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.09e-06	6.02e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.09e-06	6e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.09e-06	6e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	2.08e-06	5.98e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—ALB—epilepsy syndrome	2.06e-06	5.94e-05	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.06e-06	5.92e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ADSL—epilepsy syndrome	2.06e-06	5.92e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CHRM3—epilepsy syndrome	2.04e-06	5.86e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	2.04e-06	5.86e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	2.02e-06	5.83e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.02e-06	5.81e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GLUL—epilepsy syndrome	2.02e-06	5.8e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.02e-06	5.8e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	2.01e-06	5.79e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2e-06	5.75e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—HMOX1—epilepsy syndrome	2e-06	5.74e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.98e-06	5.69e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CAT—epilepsy syndrome	1.97e-06	5.67e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—POMC—epilepsy syndrome	1.96e-06	5.64e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GPX1—epilepsy syndrome	1.96e-06	5.63e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.95e-06	5.6e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.95e-06	5.6e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.94e-06	5.59e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.92e-06	5.52e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.92e-06	5.52e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ABCB1—epilepsy syndrome	1.92e-06	5.51e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—POMC—epilepsy syndrome	1.91e-06	5.48e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	1.9e-06	5.48e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.9e-06	5.48e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.9e-06	5.47e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.9e-06	5.47e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	1.86e-06	5.34e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.85e-06	5.33e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	1.84e-06	5.31e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.83e-06	5.27e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.83e-06	5.27e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.82e-06	5.24e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	1.82e-06	5.23e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—epilepsy syndrome	1.81e-06	5.2e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.8e-06	5.17e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ALB—epilepsy syndrome	1.79e-06	5.14e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GPX1—epilepsy syndrome	1.78e-06	5.12e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.78e-06	5.12e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.77e-06	5.1e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ALB—epilepsy syndrome	1.74e-06	5e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.74e-06	4.99e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.73e-06	4.99e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.73e-06	4.99e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	1.73e-06	4.97e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.73e-06	4.97e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—BCHE—epilepsy syndrome	1.72e-06	4.95e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AGT—epilepsy syndrome	1.72e-06	4.94e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.7e-06	4.89e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—APOE—epilepsy syndrome	1.68e-06	4.84e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.67e-06	4.8e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	1.66e-06	4.79e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.66e-06	4.77e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.65e-06	4.76e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.65e-06	4.76e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.65e-06	4.74e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	1.64e-06	4.73e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.63e-06	4.7e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.63e-06	4.68e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.63e-06	4.68e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	1.62e-06	4.67e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.62e-06	4.66e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TH—epilepsy syndrome	1.62e-06	4.66e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.62e-06	4.65e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.61e-06	4.62e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.59e-06	4.58e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.59e-06	4.57e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.59e-06	4.56e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.58e-06	4.54e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.56e-06	4.5e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—epilepsy syndrome	1.56e-06	4.5e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AGT—epilepsy syndrome	1.56e-06	4.49e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.56e-06	4.48e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.55e-06	4.46e-05	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.53e-06	4.41e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—APOE—epilepsy syndrome	1.53e-06	4.4e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.53e-06	4.39e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.52e-06	4.38e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—epilepsy syndrome	1.52e-06	4.37e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.51e-06	4.36e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.51e-06	4.35e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.51e-06	4.35e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.51e-06	4.33e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.5e-06	4.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.49e-06	4.29e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.49e-06	4.29e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.49e-06	4.29e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.49e-06	4.28e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TH—epilepsy syndrome	1.48e-06	4.27e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.48e-06	4.27e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.46e-06	4.2e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.45e-06	4.17e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—POMC—epilepsy syndrome	1.44e-06	4.16e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.43e-06	4.11e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.41e-06	4.07e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.41e-06	4.05e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.39e-06	3.99e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.38e-06	3.98e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.38e-06	3.97e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.38e-06	3.96e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.36e-06	3.91e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.36e-06	3.9e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.35e-06	3.89e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.34e-06	3.87e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.33e-06	3.84e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.33e-06	3.82e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.32e-06	3.81e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TH—epilepsy syndrome	1.32e-06	3.81e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ALB—epilepsy syndrome	1.32e-06	3.79e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—POMC—epilepsy syndrome	1.31e-06	3.78e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.31e-06	3.77e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.3e-06	3.75e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.3e-06	3.74e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.3e-06	3.73e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	1.3e-06	3.73e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.3e-06	3.73e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TH—epilepsy syndrome	1.29e-06	3.72e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.29e-06	3.71e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.29e-06	3.71e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.28e-06	3.7e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.28e-06	3.69e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.27e-06	3.67e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.25e-06	3.61e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.25e-06	3.61e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.24e-06	3.56e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.24e-06	3.56e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.23e-06	3.53e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.22e-06	3.52e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.22e-06	3.52e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TH—epilepsy syndrome	1.22e-06	3.51e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.21e-06	3.49e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TH—epilepsy syndrome	1.21e-06	3.47e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.21e-06	3.47e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ALB—epilepsy syndrome	1.2e-06	3.45e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.19e-06	3.42e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.19e-06	3.42e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.16e-06	3.34e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.16e-06	3.33e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—epilepsy syndrome	1.15e-06	3.32e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.11e-06	3.18e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.11e-06	3.18e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.1e-06	3.17e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.1e-06	3.16e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.09e-06	3.14e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.08e-06	3.1e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CAT—epilepsy syndrome	1.06e-06	3.06e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.06e-06	3.05e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.06e-06	3.04e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.05e-06	3.02e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.05e-06	3.01e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.04e-06	2.98e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.04e-06	2.98e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TH—epilepsy syndrome	1.03e-06	2.97e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.02e-06	2.94e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.02e-06	2.93e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.02e-06	2.92e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.01e-06	2.9e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CAT—epilepsy syndrome	1e-06	2.89e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	9.96e-07	2.87e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CAT—epilepsy syndrome	9.95e-07	2.86e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	9.9e-07	2.85e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GPX1—epilepsy syndrome	9.86e-07	2.84e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	9.76e-07	2.81e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AGT—epilepsy syndrome	9.69e-07	2.79e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	9.68e-07	2.78e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GPX1—epilepsy syndrome	9.63e-07	2.77e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APOE—epilepsy syndrome	9.5e-07	2.73e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—epilepsy syndrome	9.08e-07	2.61e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GPX1—epilepsy syndrome	9.07e-07	2.61e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GPX1—epilepsy syndrome	8.99e-07	2.59e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	8.94e-07	2.57e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—POMC—epilepsy syndrome	8.9e-07	2.56e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AGT—epilepsy syndrome	8.65e-07	2.49e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	8.61e-07	2.48e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	8.51e-07	2.45e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CAT—epilepsy syndrome	8.5e-07	2.45e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APOE—epilepsy syndrome	8.48e-07	2.44e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	8.47e-07	2.44e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AGT—epilepsy syndrome	8.44e-07	2.43e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APOE—epilepsy syndrome	8.27e-07	2.38e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	8.27e-07	2.38e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—POMC—epilepsy syndrome	8.16e-07	2.35e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALB—epilepsy syndrome	8.11e-07	2.33e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.08e-07	2.33e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	7.99e-07	2.3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TH—epilepsy syndrome	7.97e-07	2.29e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AGT—epilepsy syndrome	7.96e-07	2.29e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AGT—epilepsy syndrome	7.89e-07	2.27e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—epilepsy syndrome	7.86e-07	2.26e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOE—epilepsy syndrome	7.8e-07	2.24e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOE—epilepsy syndrome	7.73e-07	2.22e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GPX1—epilepsy syndrome	7.69e-07	2.21e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—epilepsy syndrome	7.64e-07	2.2e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALB—epilepsy syndrome	7.44e-07	2.14e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—POMC—epilepsy syndrome	7.28e-07	2.09e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—POMC—epilepsy syndrome	7.11e-07	2.04e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	7.1e-07	2.04e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AGT—epilepsy syndrome	6.74e-07	1.94e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—POMC—epilepsy syndrome	6.7e-07	1.93e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.65e-07	1.91e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—POMC—epilepsy syndrome	6.64e-07	1.91e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALB—epilepsy syndrome	6.64e-07	1.91e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOE—epilepsy syndrome	6.6e-07	1.9e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CAT—epilepsy syndrome	6.56e-07	1.89e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	6.51e-07	1.87e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALB—epilepsy syndrome	6.48e-07	1.86e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.38e-07	1.84e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALB—epilepsy syndrome	6.11e-07	1.76e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALB—epilepsy syndrome	6.05e-07	1.74e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.93e-07	1.71e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	5.81e-07	1.67e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—epilepsy syndrome	5.79e-07	1.67e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—POMC—epilepsy syndrome	5.67e-07	1.63e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—epilepsy syndrome	5.67e-07	1.63e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	5.34e-07	1.54e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	5.3e-07	1.52e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—epilepsy syndrome	5.27e-07	1.52e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.2e-07	1.5e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALB—epilepsy syndrome	5.17e-07	1.49e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.1e-07	1.47e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.52e-07	1.3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.38e-07	1.26e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.99e-07	1.15e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—epilepsy syndrome	3.57e-07	1.03e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.49e-07	1e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—epilepsy syndrome	3.27e-07	9.41e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.92e-07	8.4e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.85e-07	8.2e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.68e-07	7.72e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.66e-07	7.66e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.27e-07	6.54e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.76e-07	5.05e-06	CbGpPWpGaD
